Security key
92790C104
Viridian Therapeutics, Inc.\DE - Common Stock (VRDN)
CUSIP: 92790C104
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 101,911,273
- Total 13F shares
- 60,143,341
- Share change
- +8,254,898
- Total reported value
- $1,309,923,497
- Put/Call ratio
- 29%
- Price per share
- $21.78
- Number of holders
- 131
- Value change
- +$204,167,783
- Number of buys
- 66
- Number of sells
- 59
Report period
Q4 2023
Institutions
131
Top holders
10
VRDN full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Viridian Therapeutics, Inc.\DE SEC filings
Viridian Therapeutics, Inc.\DE company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92790C104
Recent filing periods:
Top shareholders of VRDN - Viridian Therapeutics, Inc.\DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Paradigm Biocapital Advisors LP |
13F
|
Company |
3.6%
|
3,681,747
|
$56,477,999 | — | 30 Sep 2023 | |
| Venrock Adviser, LLC |
13F
|
Company |
3%
|
3,082,622
|
$47,287,421 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.9%
|
2,993,063
|
$45,913,586 | — | 30 Sep 2023 | |
| Deep Track Capital, LP |
13F
|
Company |
2.9%
|
2,963,267
|
$45,456,516 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
2.9%
|
2,941,690
|
$45,125,525 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.4%
|
2,448,015
|
$37,552,550 | — | 30 Sep 2023 | |
| Commodore Capital LP |
13F
|
Company |
2.2%
|
2,200,000
|
$33,748,000 | — | 30 Sep 2023 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2%
|
2,007,946
|
$30,801,892 | — | 30 Sep 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.9%
|
1,890,998
|
$29,007,909 | — | 30 Sep 2023 | |
| BRAIDWELL LP |
13F
|
Company |
1.7%
|
1,735,182
|
$26,617,692 | — | 30 Sep 2023 | |
| Vivo Capital, LLC |
13F
|
Company |
1.6%
|
1,678,207
|
$25,743,695 | — | 30 Sep 2023 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1.6%
|
1,600,000
|
$24,544,000 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.4%
|
1,380,650
|
$21,179,171 | — | 30 Sep 2023 | |
| Fairmount Funds Management LLC |
13F
|
Company |
1.3%
|
1,369,623
|
$21,010,017 | — | 30 Sep 2023 | |
| Yiheng Capital Management, L.P. |
13F
|
Company |
1.2%
|
1,228,534
|
$18,845,712 | — | 30 Sep 2023 | |
| Octagon Capital Advisors LP |
13F
|
Company |
1%
|
1,067,143
|
$16,369,974 | — | 30 Sep 2023 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1%
|
1,066,343
|
$16,357,702 | — | 30 Sep 2023 | |
| Logos Global Management LP |
13F
|
Company |
1%
|
1,050,000
|
$16,107,000 | — | 30 Sep 2023 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.99%
|
1,011,205
|
$15,511,885 | — | 30 Sep 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.94%
|
962,493
|
$14,764,643 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.84%
|
859,095
|
$13,180,105 | — | 30 Sep 2023 | |
| Kynam Capital Management, LP |
13F
|
Company |
0.69%
|
699,681
|
$10,733,107 | — | 30 Sep 2023 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.66%
|
669,125
|
$10,264,378 | — | 30 Sep 2023 | |
| Artal Group S.A. |
13F
|
Company |
0.5%
|
504,978
|
$7,746,000 | — | 30 Sep 2023 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.45%
|
459,169
|
$7,043,652 | — | 30 Sep 2023 | |
| Eversept Partners, LP |
13F
|
Company |
0.43%
|
443,270
|
$6,799,762 | — | 30 Sep 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.43%
|
439,191
|
$6,737,190 | — | 30 Sep 2023 | |
| 5AM Venture Management, LLC |
13F
|
Company |
0.4%
|
410,000
|
$6,289,400 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.39%
|
401,666
|
$6,161,557 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.39%
|
399,280
|
$6,124,956 | — | 30 Sep 2023 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.35%
|
360,830
|
$5,535,132 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.33%
|
333,723
|
$5,119,313 | — | 30 Sep 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.31%
|
313,217
|
$4,804,749 | — | 30 Sep 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.29%
|
299,141
|
$4,588,821 | — | 30 Sep 2023 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.27%
|
275,000
|
$4,218,500 | — | 30 Sep 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.26%
|
262,296
|
$4,023,621 | — | 30 Sep 2023 | |
| FMR LLC |
13F
|
Company |
0.26%
|
262,188
|
$4,021,965 | — | 30 Sep 2023 | |
| MPM BioImpact LLC |
13F
|
Company |
0.25%
|
255,323
|
$3,916,655 | — | 30 Sep 2023 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.22%
|
224,339
|
$3,441,360 | — | 30 Sep 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.21%
|
215,648
|
$3,308,040 | — | 30 Sep 2023 | |
| Kopp Family Office, LLC |
13F
|
Company |
0.21%
|
214,290
|
$3,287,000 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.2%
|
205,223
|
$3,148,122 | — | 30 Sep 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.2%
|
203,441
|
$3,120,785 | — | 30 Sep 2023 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.17%
|
174,621
|
$2,679,000 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
138,177
|
$2,119,635 | — | 30 Sep 2023 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.13%
|
131,671
|
$2,020,000 | — | 30 Sep 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.13%
|
131,557
|
$2,018,084 | — | 30 Sep 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.11%
|
110,309
|
$1,692,140 | — | 30 Sep 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.11%
|
108,037
|
$1,657,287 | — | 30 Sep 2023 | |
| HighVista Strategies LLC |
13F
|
Company |
0.1%
|
104,756
|
$1,606,957 | — | 30 Sep 2023 |
Institutional Holders of Viridian Therapeutics, Inc.\DE - Common Stock (VRDN) as of Q4 2023
As of 31 Dec 2023,
Viridian Therapeutics, Inc.\DE - Common Stock (VRDN) was held by
131 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,143,341 shares.
The largest 10 holders included
FMR LLC, Paradigm Biocapital Advisors LP, VR Adviser, LLC, Deep Track Capital, LP, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, MAVERICK CAPITAL LTD, ALLIANCEBERNSTEIN L.P., and COMMODORE CAPITAL LP.
This page lists
131
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
122
Q4 2023 holders
131
Holder diff
9
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.